We demonstrate that the SC-QDP quantitates phosphoresponse heterogeneity in human acute myeloid leukemia MOLM14 cells to kinase inhibitor drugs (KIs) and identifies KI-insensitive CD34+ cells in patients diagnosed with chronic myeloid leukemia. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.